XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 43.87

Change

-0.07 (-0.16)%

Market Cap

CAD 0.54B

Volume

2.76K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-18 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.23 (-0.16%)

CAD 19.45B
ZSP:CA BMO S&P 500

-0.13 (-0.14%)

CAD 17.43B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.25 (+0.41%)

CAD 11.50B
VUN:CA Vanguard US Total Market

-0.17 (-0.15%)

CAD 10.60B
XUS:CA iShares Core S&P 500 Index ETF

-0.05 (-0.10%)

CAD 8.06B
HXS:CA Global X S&P 500 Corporate Cla..

-0.15 (-0.18%)

CAD 4.42B
VSP:CA Vanguard S&P 500 CAD hedged

+0.39 (+0.41%)

CAD 3.75B
QUU:CA Mackenzie US Large Cap Equity ..

-0.21 (-0.09%)

CAD 3.37B
XUU:CA iShares Core S&P US Total Mark..

-0.11 (-0.18%)

CAD 3.30B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.35 (+0.68%)

CAD 3.21B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 31.27% 90% A- 84% B
Dividend Return 0.80% 24% F 10% F
Total Return 32.06% 91% A- 83% B
Trailing 12 Months  
Capital Gain 32.34% 84% B 80% B-
Dividend Return 1.14% 28% F 10% F
Total Return 33.48% 79% B- 78% C+
Trailing 5 Years  
Capital Gain 98.96% 79% B- 85% B
Dividend Return 6.84% 13% F 10% F
Total Return 105.79% 75% C 83% B
Average Annual (5 Year Horizon)  
Capital Gain 14.33% 78% C+ 79% B-
Dividend Return 15.14% 74% C 77% C+
Total Return 0.81% 22% F 41% F
Risk Return Profile  
Volatility (Standard Deviation) 14.99% 38% F 55% F
Risk Adjusted Return 101.03% 66% D+ 96% N/A
Market Capitalization 0.54B 53% F 60% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.